KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Common Equity (2016 - 2026)

Insulet filings provide 16 years of Common Equity readings, the most recent being $1.5 billion for Q4 2025.

  • On a quarterly basis, Common Equity rose 25.06% to $1.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 billion, a 25.06% increase, with the full-year FY2025 number at $1.5 billion, up 25.06% from a year prior.
  • Common Equity hit $1.5 billion in Q4 2025 for Insulet, up from $1.4 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.5 billion in Q4 2025 to a low of $422.4 million in Q2 2022.
  • Median Common Equity over the past 5 years was $596.4 million (2021), compared with a mean of $804.0 million.
  • Biggest five-year swings in Common Equity: soared 892.03% in 2021 and later dropped 23.68% in 2022.
  • Insulet's Common Equity stood at $556.3 million in 2021, then fell by 14.36% to $476.4 million in 2022, then soared by 53.8% to $732.7 million in 2023, then soared by 65.36% to $1.2 billion in 2024, then increased by 25.06% to $1.5 billion in 2025.
  • The last three reported values for Common Equity were $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.5 billion (Q2 2025) per Business Quant data.